TuHURA Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HURA and other ETFs, options, and stocks.About HURA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco
CEOJames A. Bianco
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2023
Founded2023
Employees19
Employees19
HURA Key Statistics
Market cap53.74M
Market cap53.74M
Price-Earnings ratio-1.37
Price-Earnings ratio-1.37
Dividend yield—
Dividend yield—
Average volume912.72K
Average volume912.72K
High today$0.9148
High today$0.9148
Low today$0.86
Low today$0.86
Open price$0.8653
Open price$0.8653
Volume608.49K
Volume608.49K
52 Week high$5.50
52 Week high$5.50
52 Week low$0.8145
52 Week low$0.8145
Stock Snapshot
TuHURA Biosciences(HURA) stock is priced at $0.89, giving the company a market capitalization of 53.74M. It carries a P/E multiple of -1.37.
On 2025-12-19, TuHURA Biosciences(HURA) stock moved within a range of $0.86 to $0.91. With shares now at $0.89, the stock is trading +3.1% above its intraday low and -3.0% below the session's peak.
Trading volume for TuHURA Biosciences(HURA) stock has reached 608.49K, versus its average volume of 912.72K.
Over the past 52 weeks, TuHURA Biosciences(HURA) stock has traded between a high of $5.50 and a low of $0.81.
Over the past 52 weeks, TuHURA Biosciences(HURA) stock has traded between a high of $5.50 and a low of $0.81.
People also own
Based on the portfolios of people who own HURA. This list is generated using Robinhood data, and it’s not a recommendation.